Other providers build assays.
We build therapies.
We’re developing our own cell therapy to treat Type 1 Diabetes, so our range of analytical and molecular diagnostic tests have been developed to meet international manufacturing and clinical monitoring regulations from the outset. Using predominantly molecular methods we provide the accuracy, quantitation and speed of result that your, and our, advanced therapeutic medical products require.
We innovate for you
We are committed to keeping pace with your innovation and introducing rapid analytical and diagnostic methods into your manufacturing and clinical development that go beyond slow, outdated methods, whilst still meeting the US, EU and British regulatory and pharmacopoeia standards.
When you need to go beyond the norm, we offer you the opportunity to expediently and cost effectively develop validated assays that are specific to your product’s manufacturing and clinical needs.
Biosafety
Rapid sterility
Endotoxin
Adventitious agents
Mycoplasma
Residual contaminants
Viral & Cell Therapies
RCV detection
Viral insert copy #
Residual contaminants
Xenotransplantation
DPF herd establishment & monitoring.
PERV screening.
Zoonotic viruses, fungi, parasites
